Szkj.J

SZKJ.J maintains a capital structure with a debt-to-equity ratio of 2.59, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with negative net cash after subtracting total debt, suggesting potential short-term liquidity constraints. The operating cash flow of ZAR 89.63 million is relatively modest compared to the company's total liabilities of ZAR 3.99 billion, which may limit its ability to service debt without external financing.

In terms of profitability, SZKJ.J reports a return on equity (ROE) of 26.29% and a return on assets (ROA) of 7.3%, both of which are strong indicators of efficient capital utilization and asset management. These metrics suggest the company is generating solid returns for its shareholders and effectively deploying its assets to generate profit.

The company's revenue is concentrated within the Food & Drug Retailing segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to its primary market.

SZKJ.J's growth trajectory is not explicitly detailed in the provided data, but the company's operating income of ZAR 792.08 million and net income of ZAR 402.82 million indicate a stable performance in the most recent reporting period. The absence of detailed outlook data for the next fiscal year limits the ability to assess future growth potential.

The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints, which could necessitate additional financing or operational adjustments to maintain financial stability.

Recent events and filings are not detailed in the provided data, so no specific recent developments can be cited. The company's financial health and strategic direction would benefit from further analysis of its latest filings and management discussions.